Recommended Pharmacologic Agents for Smoking Cessation
For non-pregnant adults seeking smoking cessation, varenicline is the most effective first-line pharmacotherapy, followed by combination nicotine replacement therapy (NRT), with both significantly outperforming single-agent NRT or bupropion. 1
First-Line Pharmacotherapy Options
The FDA-approved first-line medications for smoking cessation in adults are:
1. Varenicline (Most Effective)
- Achieves approximately 28% cessation rates compared to 12% with placebo 2
- Acts as a partial agonist at α4β2 nicotinic acetylcholine receptors
- More effective than both NRT and bupropion based on head-to-head comparisons 1
- Common side effects include nausea, abnormal dreams, and insomnia 3
2. Combination NRT (Second Most Effective)
- Achieves approximately 31.5% cessation rates 4
- Combining long-acting (patch) plus short-acting forms (gum, lozenge, inhaler, or nasal spray) is more effective than single-agent NRT 1, 2
- Single-agent NRT achieves only 17% cessation rates versus 10% with placebo 2
3. Bupropion SR
- Achieves approximately 19% cessation rates compared to 11% with placebo 2
- Dopamine and norepinephrine reuptake inhibitor
- Less effective than varenicline or combination NRT 4
Algorithmic Approach to Selection
Start with varenicline unless contraindicated or not tolerated, then proceed as follows:
- If nausea or neuropsychiatric side effects occur with varenicline: Switch to combination NRT (patch + rapid-delivery form)
- If NRT is insufficient: Add bupropion SR to NRT
- If first-line agents fail or are contraindicated: Consider second-line agents (clonidine or nortriptyline) 5
Emerging Alternative: Cytisinicline
Recent evidence suggests cytisinicline may offer comparable efficacy to varenicline with significantly better tolerability, particularly 82% lower odds of nausea 6. This plant-based alkaloid showed higher odds of abstinence at 9-24 weeks compared to varenicline in adjusted analyses 6. While not yet FDA-approved in the US, it represents a promising alternative for patients unable to tolerate varenicline 7, 5.
Critical Implementation Points
Always combine pharmacotherapy with behavioral counseling for maximum effectiveness. Combined interventions increase cessation rates from 8% to 14% compared to minimal interventions alone 2. The most effective behavioral interventions include:
- At least 4 counseling sessions (ideally 8 or more sessions) 1
- Total contact time of 90-300 minutes 1
- Practical problem-solving skills training and social support 2
Special Population: Pregnant Persons
For pregnant individuals, behavioral counseling is the primary intervention—pharmacotherapy evidence is limited in this population 1. Intensive counseling with tailored materials about maternal and fetal health effects is most effective, with greatest benefit when quitting occurs early in pregnancy 1.
Common Pitfalls to Avoid
- Don't use single-agent NRT when combination NRT is available—you're leaving significant efficacy on the table
- Don't prescribe pharmacotherapy without behavioral support—the combination is substantially more effective than either alone 1, 2
- Don't abandon treatment after initial failure—tobacco dependence is a chronic condition requiring multiple attempts
The dose-response relationship is clear: more intensive interventions (more sessions, longer duration, combination therapy) yield better outcomes 1, 2.